Vincent R. Anicetti, Chief Operating Officer at Coherus BioSciences, Inc. (CHRS), sold 197,512 shares at $18.85 ($3.7M) on 2020-12-04, disclosed to the SEC on 2020-12-07.
Open-market sale of $3.7M CHRS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.67 | 49,756 | $929K | 25.1% |
| 2 | $18.67 | 49,756 | $929K | 25.1% |
| 3 | $18.85 | 49,000 | $924K | 24.9% |
| 4 | $18.85 | 49,000 | $924K | 24.9% |
| Total | $18.76 avg | 197,512 | $3.7M | 100% |
| Filing → |
| CHRS | SELL | 2021-01-21 | $45K | — | Filing → |
| CHRS | SELL | 2020-12-21 | $44K | — | Filing → |
| CHRS | SELL | 2020-12-09 | $324K | — | Filing → |